Yahoo Finance • 6 hours ago

1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer

• Tariff headlines, ‘Mag 7’ earnings, U.S. jobs report, and PCE inflation data will be in focus this week. • Meta is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock to buy... Full story

Yahoo Finance • 4 days ago

3 of Wall Street’s Favorite Stocks Walking a Fine Line

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly... Full story

Yahoo Finance • 4 days ago

2 High-Yield Dividend Stocks to Buy for Passive Income

Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks can do the heavy lifting. The key is focusing on companies with strong yields, reliable payouts, and recession-re... Full story

Yahoo Finance • 4 days ago

What's Next for Pfizer After the Company Pulls Its Weight Loss Drug?

The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100 billion by 2030. As a result, many top healthcare companies are vying for a piece of the market, as doing so could g... Full story

Yahoo Finance • 5 days ago

Pfizer Inc. (PFE): Among Recent Activist Investor Campaigns

We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other recent activist investor campaigns. Economic uncertainty and market v... Full story

Yahoo Finance • 8 days ago

Pfizer Inc. (PFE): Among Jeff Smith’s Top Activist Targets

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other Jeff Smith’s top activist tar... Full story

Yahoo Finance • 8 days ago

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration. At the time of writing, the S&P 50... Full story

Yahoo Finance • 12 days ago

Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?

Pfizer(NYSE: PFE) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors it would scrap development of danuglipron, its oral GLP-1 candidate for weight management. The stock has... Full story

Yahoo Finance • 13 days ago

Pfizer Inc. (PFE): “Dead Money… Close the Casket,” Says Jim Cramer

We recently published a list of 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks on Jim Cramer’s radar. On Thursday, Mad Money host Jim Cramer cautio... Full story

Yahoo Finance • 13 days ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk(NYSE: NVO), and Viking Therapeutics(NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer's latest product announcement. Early this mo... Full story

Yahoo Finance • 13 days ago

Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds?

We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best dividend-paying stocks. Dividend-paying st... Full story

Yahoo Finance • 13 days ago

Stocks making the biggest moves premarket: Apple, Nvidia, Goldman Sachs, Pfizer and more

Check out the companies making headlines before the bell. Goldman Sachs — The investment bank gained nearly 2% after reporting a top- and bottom-line beat in the first quarter. Goldman Sachs posted earnings of $14.12 per share while analys... Full story

Yahoo Finance • 16 days ago

Is Pfizer Inc. (PFE) A Cheap NYSE Stock to Invest in According to Hedge Funds?

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other cheap NYSE stocks. On March 26, Jack Caffrey... Full story

Yahoo Finance • 18 days ago

Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more

Check out the companies making headlines before the bell. Pharmaceutical stocks – Shares of U.S. companies in the pharmaceutical industry fell after President Donald Trump said late Tuesday that he's going to announce " very shortly a majo... Full story

Yahoo Finance • 19 days ago

Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Investing.com -- Goldman Sachs initiated coverage on several large-cap pharmaceutical companies, taking a cautious stance on Bristol-Myers Squibb (NYSE:BMY), Pfizer (NYSE:PFE), and AbbVie (NYSE:ABBV), while upgrading Eli Lilly (NYSE:LLY)... Full story

Yahoo Finance • 22 days ago

4 Dividend Stocks to Double Up on Right Now

Most people don't like seeing stock prices go down. It triggers a very natural emotional response associated with pain and loss. But for long-term investors, lower share prices are a good thing. There is a famous expression that the stock... Full story

Yahoo Finance • 24 days ago

Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer(NYSE: PFE) and Moderna(NASDAQ: MRNA). These two vaccine makers made small fortunes thanks to their work i... Full story

Yahoo Finance • 26 days ago

Is Pfizer Inc. (PFE) the Most Undervalued Healthcare Stock to Buy According to Analysts?

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other most undervalued healthcare stocks to buy... Full story

Yahoo Finance • 28 days ago

Pfizer Inc. (PFE): Among Blue Chip Stocks to Invest in at 52-Week Lows

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other blue chip stocks to invest in at 52-week lows. For the fir... Full story

Yahoo Finance • last month

Dexcom Appoints Jon Coleman as Chief Commercial Officer

SAN DIEGO, March 25, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibil... Full story